Cardiovascular & Hematological Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Cardiovascular & Hematological Agents. Each issue contains a series of timely in-depth/mini reviews, original research articles and drug clinical trial studies written by leaders in the field covering a range of current topics in Cardiovascular & Hematological medicinal chemistry.
Cardiovascular & Hematological Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cardiovascular & hematological drug discovery.
Michael Spartalis*, Eleftherios Spartalis, Eleni Tzatzaki, Diamantis I. Tsilimigras, Demetrios Moris, Christos Kontogiannis, Vaios Vasileios Kaminiotis, Stavroula A. Paschou, Sofia Chatzidou, Gerasimos Siasos, Vassilis Voudris and Dimitrios C. Iliopoulos
Debabrata Mukherjee, M.D is the Chairman of the Department of Internal Medicine and the Program Director for the Cardiovascular Medicine Fellowship program at the Texas Tech University Health Sciences Center at El Paso. Dr Mukherjee has been an invited lecturer at several major national and international meetings, has authored over 450 publications, edited eighteen textbooks on cardiovascular diseases and written more than 100 textbook chapters. He presently serves on several journal editorial boards, is the Editor-in-Chief of the Cardiovascular and Hematological Agents in Medicinal Chemistry, and the Cardiology Reviews and is an Associate Editor for the journal Cardiovascular & Hematological Disorders-Drug Targets.